Howland Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,198
| Closed | -$430K | – | 264 |
|
|
2023
Q4 | $430K | Sell |
5,198
-1,940
| -27% | -$148K | 0.02% | 197 |
|
|
2023
Q3 | $561K | Sell |
7,138
-56,251
| -89% | -$4.71M | 0.03% | 168 |
|
|
2023
Q2 | $5.58M | Sell |
63,389
-79,208
| -56% | -$6.82M | 0.32% | 60 |
|
|
2023
Q1 | $11.5M | Sell |
142,597
-61,742
| -30% | -$5.03M | 0.69% | 44 |
|
|
2022
Q4 | $16M | Sell |
204,339
-40,532
| -17% | -$3.29M | 0.99% | 35 |
|
|
2022
Q3 | $19.8M | Sell |
244,871
-8,750
| -3% | -$786K | 1.27% | 29 |
|
|
2022
Q2 | $22.9M | Sell |
253,621
-3,837
| -1% | -$389K | 1.41% | 22 |
|
|
2022
Q1 | $28.6M | Sell |
257,458
-1,066
| -0.4% | -$113K | 1.54% | 21 |
|
|
2021
Q4 | $26.7M | Sell |
258,524
-11,501
| -4% | -$1.33M | 1.36% | 24 |
|
|
2021
Q3 | $33.8M | Buy |
270,025
+321
| +0.1% | +$41.5K | 1.78% | 16 |
|
|
2021
Q2 | $33.5M | Buy |
269,704
+1,426
| +0.5% | +$179K | 1.73% | 16 |
|
|
2021
Q1 | $31.7M | Buy |
268,278
+22,402
| +9% | +$2.63M | 1.77% | 16 |
|
|
2020
Q4 | $28.8M | Buy |
245,876
+23,192
| +10% | +$2.55M | 1.69% | 19 |
|
|
2020
Q3 | $23.1M | Sell |
222,684
-120
| -0.1% | -$12.1K | 1.52% | 21 |
|
|
2020
Q2 | $20.4M | Buy |
222,804
+1,231
| +0.6% | +$118K | 1.46% | 23 |
|
|
2020
Q1 | $20M | Sell |
221,573
-1,376
| -0.6% | -$146K | 1.75% | 14 |
|
|
2019
Q4 | $25.3M | Buy |
222,949
+288
| +0.1% | +$31.6K | 1.8% | 17 |
|
|
2019
Q3 | $24.2M | Buy |
222,661
+5,125
| +2% | +$535K | 1.83% | 14 |
|
|
2019
Q2 | $21.2M | Sell |
217,536
-13,559
| -6% | -$1.24M | 1.64% | 16 |
|
|
2019
Q1 | $21M | Buy |
231,095
+9,390
| +4% | +$840K | 1.71% | 18 |
|
|
2018
Q4 | $20.2M | Sell |
221,705
-6,050
| -3% | -$565K | 1.9% | 14 |
|
|
2018
Q3 | $22.4M | Buy |
227,755
+22,956
| +11% | +$2.12M | 1.7% | 19 |
|
|
2018
Q2 | $17.5M | Buy |
204,799
+4,005
| +2% | +$335K | 1.4% | 23 |
|
|
2018
Q1 | $16.1M | Buy |
200,794
+485
| +0.2% | +$40K | 1.3% | 24 |
|
|
2017
Q4 | $16.2M | Buy |
200,309
+7,332
| +4% | +$587K | 1.29% | 29 |
|
|
2017
Q3 | $15M | Sell |
192,977
-130
| -0.1% | -$10.8K | 1.24% | 31 |
|
|
2017
Q2 | $17.1M | Sell |
193,107
-797
| -0.4% | -$67.2K | 1.45% | 26 |
|
|
2017
Q1 | $15.6M | Buy |
193,904
+290
| +0.1% | +$22.7K | 1.35% | 29 |
|
|
2016
Q4 | $13.8M | Buy |
193,614
+14,760
| +8% | +$1.16M | 1.29% | 31 |
|
|
2016
Q3 | $15.5M | Buy |
178,854
+65
| +0% | +$5.66K | 1.44% | 24 |
|
|
2016
Q2 | $15.5M | Buy |
178,789
+2,139
| +1% | +$173K | 1.46% | 21 |
|
|
2016
Q1 | $13.2M | Buy |
176,650
+169
| +0.1% | +$12.7K | 1.35% | 29 |
|
|
2015
Q4 | $13.6M | Buy |
176,481
+7,110
| +4% | +$535K | 1.38% | 26 |
|
|
2015
Q3 | $11.3M | Buy |
169,371
+2,844
| +2% | +$209K | 1.24% | 34 |
|
|
2015
Q2 | $12.3M | Buy |
+166,527
| New | +$12.7M | 1.26% | 33 |
|
|
2015
Q1 | – | Sell |
-164,914
| Closed | -$11.9M | – | 199 |
|
|
2014
Q4 | $11.9M | Sell |
164,914
-885
| -0.5% | -$61.5K | 1.19% | 38 |
|
|
2014
Q3 | $10.3M | Sell |
165,799
-5,110
| -3% | -$325K | 1.06% | 42 |
|
|
2014
Q2 | $10.9M | Sell |
170,909
-80
| -0% | -$4.86K | 1.11% | 43 |
|
|
2014
Q1 | $10.5M | Buy |
170,989
+18,590
| +12% | +$1.08M | 1.19% | 37 |
|
|
2013
Q4 | $8.75M | Sell |
152,399
-625
| -0.4% | -$35.4K | 1.09% | 43 |
|
|
2013
Q3 | $8.15M | Sell |
153,024
-8,889
| -5% | -$478K | 1.11% | 41 |
|
|
2013
Q2 | $8.33M | Buy |
+161,913
| New | +$8M | 1.32% | 32 |
|
Other funds holding MDT
Howland Capital Management's MDT Position: Q1 2024 in Review
Howland Capital Management sold out of Medtronic (MDT) in Q1 2024, closing a stake of 5,198 shares — an estimated $430K sold.
Howland Capital Management first reported a position in MDT in Q2 2013 and held it in 42 quarters. The position peaked at $33.8M in Q3 2021. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.
- Howland Capital Management reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
- Howland Capital Management sold 5,198 Medtronic shares in Q1 2024, an estimated $430K.
- Howland Capital Management first reported a position in Medtronic in Q2 2013 and held it in 42 quarters.
- Howland Capital Management's Medtronic position peaked at $33.8M in Q3 2021.
- 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.
Based on Howland Capital Management's 13F filing for Q1 2024, filed 3 May 2024.